ArticleJournal of Alzheimer's disease reports2022

Under-Represented Populations Left Out of Alzheimer's Disease Treatment with Aducanumab: Commentary on Ethics.

Sanjana P Padala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.